Primary bone tumors of the spine are rare, accounting for only 4.2% of spinal tumors. This study summarizes the experience of treating 18 cases of primary bone tumors of the spine over 10 years at two hospitals in Bangladesh. The most common tumors were malignant (61%), with the dorsal and lumbar spine being most commonly involved. Pain was the primary presenting symptom in most cases. Surgical treatment with the aim of complete resection when possible combined with preservation of neurological function and spinal stabilization was performed. Adjuvant chemotherapy and radiation were also used. Outcomes were improved pain and function, though malignant tumors often had poorer outcomes and higher mortality. Early diagnosis and multidisciplinary treatment were concluded to be important for managing these rare tumors
Vertebral Column Tumors
Primary tumors: These tumors occur in the vertebral column, and grow either from the bone or disc elements of the spine. They typically occur in younger adults. Osteogenic sarcoma (osteosarcoma) is the most common malignant bone tumor. Most primary spinal tumors are quite rare and usually grow slowly.
Metastatic tumors: Most often, spinal tumors metastasize (spread) from cancer in another area of the body , These tumors usually produce pain that does not get better with rest, may be worse at night, and is often accompanied by other signs of serious illness (such as weight loss, fever/chills/shakes, nausea or vomiting).
This presentation reviews the current neurosurgical management of patients with medulloblastoma, including the data on molecular subtyping; uses “medulloblastoma” as a springboard to discuss other topics / tumor cell biology in general; and formulates research questions to further advance neurosurgical basic science.
A comprehensive presentation on the epidemiology, pathophysiology, clinical presentation, decision making and treatment options of spinal metastases. Supported with the best available evidence as of October 6, 2008
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
Vertebral Column Tumors
Primary tumors: These tumors occur in the vertebral column, and grow either from the bone or disc elements of the spine. They typically occur in younger adults. Osteogenic sarcoma (osteosarcoma) is the most common malignant bone tumor. Most primary spinal tumors are quite rare and usually grow slowly.
Metastatic tumors: Most often, spinal tumors metastasize (spread) from cancer in another area of the body , These tumors usually produce pain that does not get better with rest, may be worse at night, and is often accompanied by other signs of serious illness (such as weight loss, fever/chills/shakes, nausea or vomiting).
This presentation reviews the current neurosurgical management of patients with medulloblastoma, including the data on molecular subtyping; uses “medulloblastoma” as a springboard to discuss other topics / tumor cell biology in general; and formulates research questions to further advance neurosurgical basic science.
A comprehensive presentation on the epidemiology, pathophysiology, clinical presentation, decision making and treatment options of spinal metastases. Supported with the best available evidence as of October 6, 2008
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
Study of current pattern of Cervical Spondylotic Myelopathy and to evaluate t...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
Radiotherapy in the Treatment of Sarcomas in Adolescents and Young AdultsMethodist HealthcareSA
Daniel Indelicato, MD, University of Florida, Jacksonville, FL
Presented at the 2010 Texas Adolescent and Young Adult Oncology Conference, Methodist Healthcare-San Antonio
Is a Bone Metastasis Common with Colon Cancer? A Case Reportasclepiuspdfs
It is well recognized that bone is a rare site of metastasis from colorectal cancer (CRC). The data available regarding skeletal metastasis from CRC are limited. We report a rare case of bone metastasis from a colon cancer of 37-year-old Saudi women and review of literature.
Sarcoma is one of the leading cancer centers in Washington DC providing the best musculoskeletal cancer surgery. Dr. Martin Malawer is a highly specialized surgeon who had pioneered in the field of limb-sparing surgery.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
1. Primary bone tumour of the spine :
Experience of 18 cases.
Dr. Md. Shafiul Alam
Associate Professor
National Institute of Neurosciences & Hospital
2.
3. Introduction
Primary bone tumour of the spine is a heterogynous group
of conditions that includes both benign and malignant
tumours, with only 6% of these tumours considered
malignant.
4. The spine is a frequent site of metastasis but primary
bone tumour of the spine are rare and make up only
4.2% of spinal tumour.
Eleven percent (11%) of primary musculoskeletal tumour
occur in the spine with certain tumours having an affinity
for the spine.
5. Although rare, these tumour offer a considerable
diagnostic dilemma and therapeutic challenge.
Timely diagnosis is crucial, as immediate attention could
affect overall prognosis.
6. The most common primary tumour of the spine is
metastatic deposits.
A number of both benign and malignant tumours may
arise primarily from the spine.
9. Primary bone tumours are more common in the
thoracic and lumbosacral regions than in the cervical
spine.
These tumours occur according to a typical anatomical
distribution within the vertebra. In general, malignant
tumours occur more frequently in the anterior elements
and benign tumours in the posterior elements.
10. The aims of treatment of these axial neoplasms include
complete resection if feasible, preservation of
neurological function and stabilisation of the spine if
needed.
The aim of our study was to review the primary bone
tumours of the spine treated at our unit regarding the
presentation, the surgical strategy employed and the
outcome.
11. Materials and methods
This is a retrospective study.
All the primary bone tumours of the spine that received
surgical treatment at the department of Neurosurgery of
Dhaka Medical College Hospital and National Institute of
Neurosciences and Hospital Dhaka, Bangladesh from
2007 to 2016 were included in this study.
We excluded all secondary deposition in the spine.
12. Materials and Methods
We treated 18 cases during this period that were included
according to these criteria.
A case note and imaging review was done where patient
demographics, details of presentation, clinical information
and the management strategy were analyzed.
All complications and mortalities were recorded.
13. Results
Between 2007 and 2016, a total 18 patients were diagnosed as primary
bone tumour of the spine.
The median age at presentation was 36 years (range 14 to 49 years)
with eleven(61.12%) male and seven(38.88%) female patients affected.
The median follow-up was 12 months (range 3 to 36 months).
14. Table 1 : Distribution of patient by age.
Age group Frequency Percentage
0 to 10 years 0 0
11 to 20 years 3 16.67
21 to 30 years 7 38.89
31 to 40 years 4 22.22
41 to 50 years 4 22.22
Total 18 100
15. Table 2 : Distribution of patient by sex.
Sex Frequency Percentage
Male 11 61.12
Female 7 38.88
Total 18 100
17. Table 3 : Distribution of patient by site of involvement.
Site of involvement Frequency Percentage
Cervical 1 5.55
Dorsal 7 38.89
Lumber 6 33.34
Sacrum 4 22.22
Total 18 100
18. Distribution of tumour according to the site :
0
1
2
3
4
5
6
7
Cervical Dorsal Lumber Sacrum
19. Investigation
The most utilized diagnostic tool was MRI and CT scan of
the spine. It helped to diagnose the case as well as
planning of surgery.
X ray is no longer a standard diagnostic tool of spine
tumour, it was used in all cases as a complimentary
diagnostic tool. It also helped to find out the extra spinal
involvement like rib cases in two cases.
20. Pre-operative CT guided FNAC was done in seven cases.
Post-operative histopathological study was done in all cases.
21. Primary bone tumour of the spine most commonly
involved the dorsal (38.89%) and the Lumber (33.34%).
It affect the sacral (22.22%) and the cervical spine
(5.55%) less frequently.
25. Pain was the most common presenting symptom (15 from 18
cases) and four cases presented with pain alone.
Pain was mostly axial pain in the affected region (11 of 18
cases), although three patients presented with chest pain and
one with flank pain.
Other presenting symptoms included neurological symptoms
and odynophagia
26. Recurance of tumor
Two of the recurrent cases were in malignant tumours
and one in benign aggressive tumour.
In the one recurrent malignant tumour a repeat
attempted marginal resection was performed.
The other two recurrent cases were not re-operated as
resection was not possible with acceptable morbidity.
We had five deaths in the series.
35. Discussion
The most common presenting complaint of patients with
primary tumour is pain, with roughly 60% complaining of axial
pain and 25% of radicular symptoms.
The presence of a neurological deficit carries a worse
prognosis. Pain at rest or night pain is red flag symptoms that
warrant further investigation. Spinal deformity is obvious
when present, but occurs in less than 10% of patients.
36. The most common cause of a painful scoliosis in adolescents is
an osteoid osteoma. A delay in diagnosis is common and our
finding is confirmed in other series.
This is due to the presenting symptoms often being vague,
pain often being the only symptom, and the initial radiographs
often only showing subtle or no abnormalities leading to the
symptoms not being properly investigated.
37. Most patients report a slow, gradual onset of pain in the
involved area. In benign tumours of the spine an average of
26 weeks of symptoms before presentation are reported.
This was confirmed in our series where the average delay in
presentation was 7 months.
38. Recent advances in chemotherapy have led to improved survival in
malignant primary bone tumour, including in the spine.
Adjuvant radiotherapy is indicated in malignant and some benign
aggressive lesions.
The use of local radiotherapy does increase the risk of major local
complications, including sepsis. We used radio- and chemotherapy
in a number of cases as guided by oncology unit.
.
39. Limitation of the study
The main limitations of this study are the retrospective
character and the relatively small numbers.
40. Conclusion
Most primary bone tumour of the spine in our study occurred
in adults and were malignant.
Surgical treatment resulted in pain reduction and neurological
improvement, allowing a rapid adjuvant therapy in good
clinical condition.
41. Malignant hematopoietic tumors had an intermediate one-
year prognosis ranging between benign and other malignant
PBTS.
Although hematopoietic tumors are characterized by early
systemic spread, spinal surgeons may well manage the ones
presenting with acute primary spinal manifestation.
42. An experienced multidisciplinary team of tertiary care center
should perform diagnosis and treatment of these extremely
rare tumors.
43. We conclude that primary bone tumours of the spine are
often associated with a significant delay in diagnosis.
Surgical strategy and adjuvant therapy should be
individualised for each case.
Acceptable results with minimal complications can be
achieved with this approach.